ICD code T38.5X2S – Estrogen and progestogen poisoning, intentional self-harm, sequela

Key takeaways

T38.5X2S is the billable ICD-10-CM code for a later visit that treats a condition caused by an intentional estrogen or progestogen poisoning.

Code the residual condition first as the principal diagnosis, then T38.5X2S as its cause, per ICD-10-CM Guidelines Section I.B.10.

T38.5X2A covers active treatment of the poisoning, and T38.5X2D covers routine recovery follow-up. Neither situation takes the S character.

Only the provider can document self-harm intent. When the note is unclear, query the provider before assigning the code.

Using T38.5X2S for an encounter where the poisoning is still being treated is the leading cause of denials on this code.

ICD-10 code T38.5X2S: Definition and billable status

ICD-10 code T38.5X2S is the fully specified, billable ICD-10-CM code for “Poisoning by other estrogens and progestogens, intentional self-harm, sequela.” It is valid for claims submitted under CMS ICD-10-CM FY2025 and FY2026, and the current addenda carry no deletion notice for it. The code can’t be assigned while the poisoning is under active treatment, which is the job of T38.5X2A. Routine recovery follow-up for the poisoning itself takes T38.5X2D. T38.5X2S is reserved for a later encounter focused on the residual condition the poisoning left behind.

Use this code reference table to confirm the key facts before claim submission:

What each character in T38.5X2S means

Each character in T38.5X2S encodes a specific clinical and encounter-type fact. Misreading position 6 (intent) or position 7 (encounter type) causes most coding errors in this code family. The table below maps every character to its meaning.

The placeholder X at position 5 carries no clinical meaning. It exists solely to push the intent character into position 6 and the encounter-type character into position 7. Omitting it produces an invalid code that payers reject outright. So does coding the parent T38.5X2 without a seventh character. The CDC/NCHS ICD-10-CM web tool flags T38.5X2 as a non-billable parent. Only the seven-character forms, such as T38.5X2S and its A and D siblings, are reportable.

Which drugs and substances does T38.5X2S cover?

T38.5X2S covers poisoning involving the drug classes listed under “other estrogens and progestogens” in the ICD-10-CM Table of Drugs and Chemicals. These include both estrogen-containing and progestogen-containing preparations. Confirm each substance against the official table rather than memory or product labeling.

• Conjugated estrogens (e.g., Premarin and generic equivalents)
• Synthetic estrogens (e.g., ethinyl estradiol, estradiol valerate)
• Progestins and progestogens (e.g., medroxyprogesterone acetate, norethisterone, levonorgestrel, progesterone)
• Combination oral contraceptives containing both an estrogen and a progestin
• Hormone replacement therapy (HRT) preparations containing estrogen or progestogen components
• Transdermal and injectable hormonal preparations in the same drug classes

Other T38 subcategories cover substances such as corticosteroids (T38.0), thyroid hormones (T38.1), and insulin (T38.3). T38.5X2S doesn’t cover them, even when they accompany an estrogen or progestogen product. Code each substance to its own T38 subcategory when multiple agents are involved.

When to use T38.5X2S: Sequela encounter criteria

T38.5X2S is applicable only when three conditions are simultaneously present in the medical record. Missing any one of them means a different code applies instead.

1. The acute poisoning episode has fully resolved. The patient is no longer in the acute or active phase of the poisoning. There is no ongoing toxic effect requiring emergency or acute-care management at this encounter.
2. A residual condition attributable to the prior poisoning is present. The provider documents a specific late effect as the reason for the current visit. Examples include persistent depressive symptoms, hormonal dysregulation, or another condition the earlier poisoning caused.
3. The prior poisoning was intentional self-harm. Provider documentation explicitly states, or clearly supports, that the original poisoning event was intentional self-harm. Coders may not infer intent from clinical presentation alone; a provider query is required when documentation is ambiguous.

The ICD-10-CM Official Guidelines, Section I.B.10, govern sequela coding across all code families. When all three criteria are met, the late effect is the principal (first-listed) diagnosis. That may be a mental health condition or another residual problem, and T38.5X2S is coded second as its cause. The decision flow below shows how the encounter and intent questions narrow the choice to one code.

T38.5X2S vs. related codes: How to choose

The T38.5X2S vs T38.5X1S distinction is the most frequent source of coding confusion in this code family. The intent character in position 6 is the only difference between the sibling codes. It must come from documented provider intent, never from inference.

T38.5X4S (undetermined) is not a fallback for ambiguous documentation. The guidelines reserve it for records that state intent can’t be determined. When intent is simply unclear, query the provider rather than defaulting to undetermined. If intent stays unknown, the guidelines default to accidental intent. The same A/D/S encounter logic applies throughout Chapter 19.

Excludes notes and sequencing rules for T38.5X2S

The T38.5 subcategory carries tabular instructions that affect sequencing and code selection. Reviewing these before assigning ICD-10 code T38.5X2S prevents both claim denials and audit flags.

• Code the sequela condition first. Per ICD-10-CM Official Guidelines Section I.B.10, the residual/late-effect condition is the principal diagnosis at the sequela encounter. T38.5X2S is sequenced after it as the cause code, never first-listed.
• No Excludes1 note blocks T38.5X2S itself. The T38 category’s Excludes1 notes send three hormone groups elsewhere: Mineralocorticoids and their antagonists (T50.0-), oxytocic hormones (T48.0-), and parathyroid hormones and derivatives (T50.9-). Separately, never assign an adverse effect code (T38.5X5-) and a poisoning code for the same substance and encounter.
• The T36-T50 block excludes drug abuse and drug dependence (F11-F19), which are reported separately when present and do not replace the poisoning code.
• No additional external cause code (X-code or Y-code) is required for intentional self-harm poisoning. The intent character “2” in T38.5X2S already encodes intent under ICD-10-CM guidelines. Some payers may still request supplementary place-of-occurrence codes; verify against individual payer policy rather than assuming they are universally required.

Additional codes to report with T38.5X2S

T38.5X2S is the etiology/cause code at a sequela encounter. It is never the only code on the claim. The claim line must include at minimum one additional code identifying the residual condition that brought the patient in.

1. Code the residual condition first (principal/first-listed diagnosis). Examples include persistent depressive disorder that emerged after the poisoning, hormonal imbalance, and neurological effects. Any other sequela the provider ties to the prior poisoning qualifies too.
2. Assign T38.5X2S as an additional diagnosis code to identify the nature and intent of the original poisoning.
3. Code co-occurring substance use or mental health disorders separately. If the provider documents one, report it as an additional code. It does not replace T38.5X2S.
4. Place, activity, and status codes (Y92.-, Y93.-, Y99.-) are optional for sequela encounters under ICD-10-CM guidelines, but specific payers may require them. Check each payer’s policy before including or omitting them.

According to the AAPC ICD-10-CM code reference, the sequela residual condition must be a distinct, separately codeable clinical entity. A vague symptom that could apply to any visit doesn’t qualify. A claim listing only T38.5X2S with no accompanying residual-condition code is incomplete and will be denied.

Documentation requirements

The medical record must contain explicit statements supporting every character in T38.5X2S before it is assignable. Ambiguous documentation is the second most common driver of denials and audits on this code, after incorrect encounter-type selection.

The provider note for a T38.5X2S encounter must document all of the following:

• Nature of the current condition: A specific residual or late-effect condition directly caused by the prior poisoning. A general wellness follow-up or unrelated complaint doesn’t qualify.
• Linkage to prior poisoning: The note must state that the current condition is a sequela of the prior estrogen or progestogen poisoning. A prior ED or inpatient record documenting the acute event supports this linkage but does not replace the current-visit documentation.
• Confirmation of intentional self-harm: The provider (not the coder) must document that the original poisoning was intentional self-harm. Acceptable language includes “intentional overdose,” “deliberate ingestion,” or a formal psychiatric assessment stating self-harm intent. Clinical presentation alone, even a high drug level, does not establish intent for coding purposes.
• Resolution of the acute poisoning: The note must support that the active toxic episode is over. If the poisoning is still under active treatment, T38.5X2A applies instead. Routine recovery follow-up for the poisoning itself takes T38.5X2D.
• Specific residual condition diagnosis: Ideally with supporting objective findings or functional assessment. Vague terms such as “history of estrogen poisoning” without a current codeable sequela are insufficient for T38.5X2S at a follow-up encounter.

When documentation is incomplete or ambiguous regarding intent or sequela status, coders should submit a provider query before assigning the code. Assigning T38.5X2S based on assumption rather than documentation creates audit liability. ICD-10-CM documentation standards require the same rigor across all diagnosis code families: The provider, not the coder, determines and documents the clinical facts.

Structured clinical note templates make it easier to capture the residual-condition and intent language T38.5X2S requires. When those fields are part of every follow-up note, fewer claims reach a payer without support.

Common coding errors and denial reasons

Most denials on ICD-10 code T38.5X2S trace to a handful of recurring errors. Catching them at coding review, before submission, costs far less than working them through appeals. A clearinghouse front-end edit check also catches many of them before the claim reaches a payer adjudicator.

• Using T38.5X2S for the active poisoning encounter. Every encounter where the poisoning is under active treatment, including ED visits and inpatient toxicology management, requires T38.5X2A. T38.5X2S is only correct when the visit treats a late effect of the resolved poisoning.
• Wrong intent character. Coders apply T38.5X2S when documentation supports accidental exposure (T38.5X1S) or doesn’t specify intent. Providers must document intent; coders must not assign the intentional self-harm character without that documentation.
• Omitting the sequela condition code. Billing T38.5X2S as the only diagnosis code, with no principal residual-condition code, results in an automatic denial. The code explains a cause and can’t stand alone as a diagnosis.
• Using the non-specific parent T38.5X2 without the seventh character. The parent code without “S”, “A”, or “D” is not a valid billable code. Every claim must include the full seven-character code.
• Incorrect sequencing. Placing T38.5X2S as the principal/first-listed diagnosis rather than the accompanying etiology code. The sequela condition is always first-listed per ICD-10-CM Guidelines Section I.B.10.
• Missing or ambiguous provider documentation of intentional self-harm. Payers flag T38.5X2S claims that lack supporting documentation of self-harm intent. A provider query and updated note are required before resubmission.

Flagging Chapter 19 poisoning codes for documentation review before submission cuts rework for coding and billing teams. A clean claim for T38.5X2S carries the full seven-character code and a paired residual-condition principal diagnosis. It also needs documented provider support for both intent and sequela status.

Payer rules and prior authorization

Medicare, Medicaid, and commercial payers apply different coverage and documentation standards to intentional self-harm sequela claims. Knowing them prevents denials that clear documentation alone can’t stop.

• Medicare: CMS does not publish a national coverage determination (NCD) specifically excluding T38.5X2S. Medicare Administrative Contractors (MACs) may publish Local Coverage Determinations (LCDs) affecting related mental health services billed alongside T38.5X2S. Check your MAC’s LCD database before assuming blanket coverage.
• Medicaid: State Medicaid programs vary in how they handle intentional self-harm sequela claims. Some states require a psychiatric evaluation code alongside T38.5X2S for outpatient follow-up visits. Billing staff should verify state-specific policy directly with the relevant Medicaid managed care organization (MCO).
• Commercial payers and mental health parity: The federal Mental Health Parity and Addiction Equity Act (MHPAEA) applies here. Commercial payers generally can’t limit mental health coverage more tightly than medical and surgical coverage. Sequela encounters for psychiatric late effects of self-harm poisoning may invoke parity protections, though specific application depends on plan type and state law. Do not assert parity rights without confirming plan details and applicable state statutes.
• Prior authorization: Requirements for T38.5X2S encounters vary by payer and by the services billed, such as psychiatric evaluation, psychotherapy, or follow-up E/M visits. The poisoning sequela code itself does not trigger a universal PA requirement. The billed procedure codes drive that determination.
• Inpatient vs. outpatient sequela coding: Sequela encounter coding rules are consistent between inpatient and outpatient settings per ICD-10-CM guidelines. However, payer payment policies, DRG grouping, and facility billing rules differ by setting. The differences matter most for inpatient stays that begin with an acute poisoning.

Behavioral health practices that see many self-harm sequela patients need payer-specific billing rules set up alongside structured ICD-10-CM documentation. Keeping payer LCD and parity references current reduces audit exposure on sensitive claim categories like T38.5X2S.

Electronic remittance advice (ERA) data is the most useful source for spotting payer-specific denial patterns on T38.5X2S claims. Sorting ERA lines by CARC denial codes shows whether missing documentation, sequencing errors, or payer policy drives each denial. Billing teams can then fix the cause instead of resubmitting the same claim.

How Pabau catches T38.5X2S claim errors before submission

Many billing teams still check poisoning sequela claims by hand. Someone confirms the late effect is listed first, the seventh character is S, and the note states self-harm intent. Each missed check comes back weeks later as a denial.

Practice management software like Pabau moves those checks ahead of the claim. Pabau’s claims management software sends claims through Claim.MD, whose front-end edits flag invalid codes and sequencing errors before a payer sees them.

The provider’s note, the diagnosis codes, and the claim sit in the same patient record. Coders can check the intent and sequela language without requesting a separate chart, so fewer T38.5X2S claims go out unsupported.

Reduce ICD-10 claim denials with Pabau

Pabau’s claims management software works with Claim.MD to check ICD-10-CM codes and sequencing before submission, so errors get fixed before a payer sees them.

Book a demo

Conclusion

Treat T38.5X2S as a second-line code. Code the late effect first and T38.5X2S after it. Before the claim goes out, confirm the acute poisoning has resolved and the provider’s note states self-harm intent.

The trade-off is a slower coding review on a small share of claims. That time costs less than an appeal, and far less than an audit on a self-harm diagnosis.

Book a demo to see how Pabau flags sequencing and documentation errors on poisoning sequela claims before they reach a payer.

Continue your research

Handling high volumes of behavioral health ICD-10 claims? Revenue cycle management for healthcare practices covers the end-to-end billing workflow from diagnosis coding through payment posting.

Want to reduce denials on complex diagnosis codes? Denial codes in medical billing explains the most common CARC codes that affect Chapter 19 poisoning and sequela claims.

Building a repeatable denial process? Denial management in healthcare sets out how to track, appeal, and prevent claim denials.

Reading payer responses line by line? Electronic remittance advice explains how ERA data shows why a claim was paid or denied.

Worried about audit exposure on self-harm claims? Medical billing compliance covers the rules and documentation habits that keep claims defensible.

Frequently asked questions